Patent Yard Sign in
Expired Australian patentAustralia

Alkynyl containing hydroxamic acid derivatives their preparation and their use as matrix metalloproteinase MMP inhibitors/TNF-alpha converting enzyme TACE inhibitors

AU 2000026305 · Applicant: Wyeth Holdings Corporation

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 27, 2000 and granted May 20, 2004. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by January 27, 2021.
  • A pharmaceutical extension adds at most five years, so even that would have ended by January 27, 2026.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 27, 2000
GrantedMay 20, 2004
Term ended byJanuary 27, 2021
Application numberAU 2000026305
Classification (IPC)A61K31/351 +2 more

Timeline

Timeline From IP Australia dates

2001200420072010201320162019Application filedJan 27, 2000Patent grantedMay 20, 2004Term ended byJan 27, 2021

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.